The IMID Forum
By The Immune-Mediated Inflammatory Disease Forum
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Education
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 414
Description
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
| Episode | Date |
|---|---|
|
Discussing RA: Advanced therapy outcomes in RA
|
Jul 30, 2026 |
|
Author Interview: Professor Laura Coates, July 2026
|
Jul 22, 2026 |
|
Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
|
Jul 16, 2026 |
|
Author Interview: Dr Murat Torgutalp, June 2026
|
Jul 09, 2026 |
|
Discussing RA: Infectious complications of RA treatments
|
Jun 25, 2026 |
|
Author Interview: Doctor Chung-Mao Kao, May 2026
|
Jun 23, 2026 |
|
Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement
|
Jun 18, 2026 |
|
EULAR 2026 Review Podcast
|
Jun 12, 2026 |
|
EULAR 2026 Day 4 Highlights Podcast
|
Jun 06, 2026 |
|
EULAR 2026 Day 3 Highlights Podcast
|
Jun 05, 2026 |
|
EULAR 2026 Day 2 Highlights Podcast
|
Jun 04, 2026 |
|
EULAR 2025 Day 1 Highlights Podcast
|
Jun 03, 2026 |
|
Discussing RA: Comparative outcomes with upadacitinib in RA
|
May 28, 2026 |
|
EULAR 2026 Preview Podcast
|
May 27, 2026 |
|
Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
|
May 15, 2026 |
|
Author Interview: Professor Valentino Paci, April 2026
|
Apr 30, 2026 |
|
Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure
|
Apr 30, 2026 |
|
Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
|
Apr 14, 2026 |
|
Author Interview: Professor Helena Marzo-Ortega, March 2026
|
Apr 09, 2026 |
|
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
|
Mar 26, 2026 |
|
Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers
|
Mar 19, 2026 |
|
Author Interview: Doctor Carlo Tur, February 2026
|
Mar 12, 2026 |
|
Author Interview - Professor Andrew Cope, 2026
|
Mar 05, 2026 |
|
Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA
|
Feb 27, 2026 |
|
Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes
|
Feb 13, 2026 |
|
Author Interview: Professor Matthew Brown, 2026
|
Feb 03, 2026 |
|
Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis
|
Jan 29, 2026 |
|
Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA
|
Dec 18, 2025 |
|
Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
|
Dec 11, 2025 |
|
Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA
|
Dec 04, 2025 |
|
Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA
|
Nov 27, 2025 |
|
Author Interview: Professor Filip Rob, 2025
|
Nov 20, 2025 |
|
Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2
|
Nov 16, 2025 |
|
Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis
|
Nov 13, 2025 |
|
Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab
|
Nov 06, 2025 |
|
ACR 2025 Review Podcast
|
Nov 05, 2025 |
|
ACR Daily Highlights Day 4
|
Oct 29, 2025 |
|
ACR Daily Highlights: Day 3
|
Oct 28, 2025 |
|
Pathways Modulating IMIDs: Webinar Highlights Podcast
|
Oct 28, 2025 |
|
ACR Daily Highlights: Day 2
|
Oct 27, 2025 |
|
ACR Daily Highlights: Day 1
|
Oct 26, 2025 |
|
ACR 2025 Preview Podcast
|
Oct 22, 2025 |
|
Discussing PsA: Comparative effectiveness of biologic and targeted therapies in PsA: Insights from PARWCH and KEEPsAKE studies
|
Oct 09, 2025 |
|
Author Interview: Doctor David Kellner, September 2025
|
Oct 02, 2025 |
|
Discussing RA: Safety and vaccine immunogenicity of upadacitinib across immune-mediated diseases
|
Sep 25, 2025 |
|
Discussing axSpA: Comparative real-world effectiveness of biologic and targeted therapies in axSpA
|
Sep 18, 2025 |
|
Discussing RA: Efficacy and safety of upadacitinib for patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
|
Sep 04, 2025 |
|
Author Interview: Doctor Rodrigo Garcia‑Salinas, August 2025
|
Aug 28, 2025 |
|
Author Interview: Doctor Martin Schaefer and Professor Anja Strangfeld, July 2025
|
Aug 14, 2025 |
|
Discussing PsA: Post hoc analyses on secukinumab and deucravacitinib from Phase 2 and 3 trials
|
Aug 07, 2025 |
|
Discussing RA: Comparative outcomes of JAK inhibition and TNF blockade vs dual JAK–ROCK targeting
|
Jul 31, 2025 |
|
Discussing axSpA: Secukinumab treatment outcomes on sustained remission and skeletal health in axSpA
|
Jul 10, 2025 |
|
Difficult-to-treat disease in Rheumatology Podcast Professors Iain McInnes and Peter Nash
|
Jul 03, 2025 |
|
EULAR 2025 Review Podcast
|
Jul 02, 2025 |
|
Discussing RA: Impact of TOF on BMI, UPA monotherapy in MTX-IRs, and JAKis vs TNFis treatment
|
Jun 26, 2025 |
|
EULAR 2025 Highlights: Day 4
|
Jun 14, 2025 |
|
EULAR 2025 Highlights: Day 3
|
Jun 13, 2025 |
|
Discussing PsA: Real-world data on biologic switching and the development of EMMs
|
Jun 12, 2025 |
|
EULAR 2025 Highlights: Day 2
|
Jun 12, 2025 |
|
EULAR 2025 Highlights: Day 1
|
Jun 11, 2025 |
|
EULAR 2025 Preview Podcast
|
Jun 09, 2025 |
|
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
|
Jun 05, 2025 |
|
Podcast: AuToDeCRA, June 2025
|
Jun 04, 2025 |
|
Webinar Highlights Podcast: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs
|
May 28, 2025 |
|
Author Interview: Dr Saqr Alsakarneh, May 2025
|
May 22, 2025 |
|
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
|
May 08, 2025 |
|
Discussing RA: MACE, VTE, and malignancy in filgotinib RA and UC patients, and MACE related to JAKis
|
May 01, 2025 |
|
Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
|
Apr 16, 2025 |
|
Discussing PsA: JAKi Comparative safety & Burden and determinants of multi‑b/tsDMARD failure in PsA
|
Apr 03, 2025 |
|
Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs
|
Mar 27, 2025 |
|
Author Interview: Professor Phillip Helliwell, March 2025
|
Mar 20, 2025 |
|
Author Interview: Professor Phillip Helliwell, 2025
|
Mar 13, 2025 |
|
Discussing PsA: Bimekizumab improves patient-reported outcomes and work productivity
|
Mar 06, 2025 |
|
Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
|
Feb 27, 2025 |
|
Discussing axSpA: Long-term safety and efficacy of Bimekizumab results from BE-AGILE & BE-MOBILE 1/2
|
Feb 27, 2025 |
|
Author Interview: Professor Denis McGonagle, 2025
|
Feb 06, 2025 |
|
Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy
|
Jan 23, 2025 |
|
Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib
|
Dec 19, 2024 |
|
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
|
Dec 19, 2024 |
|
ACR 2024 Review Podcast
|
Nov 28, 2024 |
|
Discussing PsA: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses
|
Nov 28, 2024 |
|
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
|
Nov 14, 2024 |
|
Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases
|
Nov 13, 2024 |
|
ACR 2024 Highlights: Day 3
|
Nov 11, 2024 |
|
ACR 2024 Highlights: Day 2
|
Nov 11, 2024 |
|
ACR 2024 Highlights: Day 1
|
Nov 11, 2024 |
|
ACR 2024: Preview Podcast
|
Nov 11, 2024 |
|
AxSpA Podcast: Efficacy and Safety of IV secukinumab
|
Oct 31, 2024 |
|
Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy
|
Oct 31, 2024 |
|
Author Interview: Derin Karacabeyli, 2024
|
Oct 10, 2024 |
|
Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases
|
Oct 07, 2024 |
|
PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA
|
Sep 26, 2024 |
|
Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials
|
Sep 19, 2024 |
|
Discussing AxSpA: Incidence of uveitis following bimekizumab treatment
|
Aug 29, 2024 |
|
Author Interview: Professor Laura Andreoli, 2024
|
Aug 22, 2024 |
|
Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib
|
Aug 15, 2024 |
|
Discussing AxSpA: Bimekizumab in AxSpA & Secukinumab Patient Clustering
|
Aug 12, 2024 |
|
Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies
|
Aug 12, 2024 |
|
Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice
|
Aug 12, 2024 |
|
Discussing RA: January 2024
|
Aug 12, 2024 |
|
Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs
|
Aug 12, 2024 |
|
Discussing RA: February 2024
|
Aug 12, 2024 |
|
Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment
|
Aug 12, 2024 |
|
Discussing RA: March 2024
|
Aug 12, 2024 |
|
Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population
|
Aug 12, 2024 |
|
Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs
|
Aug 12, 2024 |
|
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
|
Aug 12, 2024 |
|
Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab
|
Aug 12, 2024 |
|
IMID Author Interview: Dr Blanca Hernández-Cruz, 2024
|
Aug 12, 2024 |
|
Discussing PsA: Bimekizumab therapy in PsA
|
Aug 12, 2024 |
|
Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
|
Aug 12, 2024 |
|
Discussing PsA: Guselkumab and analysis of genetic markers
|
Aug 12, 2024 |
|
Author Interview: Dr Adam Goldman, 2024
|
Aug 08, 2024 |
|
Author Interview: Professor Daniel Blockmans, 2024
|
Jul 25, 2024 |
|
Discussing RA: July 2024
|
Jul 18, 2024 |
|
Discussing RA: June 2024
|
Jun 27, 2024 |
|
EULAR 2024 Review Podcast
|
Jun 19, 2024 |
|
EULAR 2024 Highlights: Day 4
|
Jun 15, 2024 |
|
EULAR 2024 Highlights: Day 3
|
Jun 14, 2024 |
|
EULAR 2024 Highlights: Day 2
|
Jun 13, 2024 |
|
EULAR 2024 Highlights: Day 1
|
Jun 12, 2024 |
|
EULAR 2024 Preview Podcast
|
Jun 10, 2024 |
|
Discussing RA: May 2024
|
Jun 06, 2024 |
|
IMID Author Interview: Dorthe Berthelsen, 2024
|
May 14, 2024 |
|
Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases
|
May 07, 2024 |
|
IMID Author Interview: Dr Jake Weddell, 2024
|
May 07, 2024 |
|
IMID Author Interview: Professor Frank Verhoeven, 2024
|
Apr 30, 2024 |
|
Discussing RA: April 2024
|
Apr 25, 2024 |
|
Author Interview: Professor Maria Antonietta D’Agostino, 2024
|
Apr 18, 2024 |
|
Author Interview: Professor Dennis McGonagle, 2024
|
Apr 16, 2024 |
|
Author Interview: Dr Jürgen Rech, 2024
|
Apr 04, 2024 |
|
Author Interview: Dr Mahta Mortezavi, 2024
|
Feb 28, 2024 |
|
Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs
|
Feb 26, 2024 |
|
Author Interview: Dr Kehinde Sunmboye, 2024
|
Feb 15, 2024 |
|
Author Interview: Professor Andrea Rubbert-Roth, 2023
|
Jan 22, 2024 |
|
Discussing Rheumatology: December 2023
|
Dec 22, 2023 |
|
PsA Podcast: Impact of Biological Sex on Advanced Therapies & Upadacitinib-related Malignancies
|
Dec 22, 2023 |
|
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
|
Dec 04, 2023 |
|
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
|
Dec 01, 2023 |
|
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
|
Dec 01, 2023 |
|
Discussing Rheumatology: November 2023
|
Nov 23, 2023 |
|
ACR 2023 Highlights: Day 4
|
Nov 15, 2023 |
|
ACR 2023 Highlights: Day 3
|
Nov 14, 2023 |
|
ACR 2023 Highlights: Day 2
|
Nov 13, 2023 |
|
ACR 2023 Highlights: Day 1
|
Nov 12, 2023 |
|
ACR 2023 Preview Podcast
|
Nov 09, 2023 |
|
Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
|
Oct 31, 2023 |
|
axSpA Podcast: Safety and Efficacy of Upadacitinib
|
Oct 26, 2023 |
|
CSF Author Interview: Dr. David Martin, 2023
|
Oct 26, 2023 |
|
Discussing Rheumatology: October 2023
|
Oct 20, 2023 |
|
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer
|
Oct 16, 2023 |
|
CSF Author Interview: Professor Martin Bergman, 2023
|
Oct 11, 2023 |
|
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
|
Oct 11, 2023 |
|
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
|
Sep 25, 2023 |
|
Discussing Rheumatology: September 2023
|
Sep 25, 2023 |
|
Author Interview: Sofia Ramiro
|
Aug 31, 2023 |
|
Discussing Rheumatology: August 2023
|
Aug 22, 2023 |
|
AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue
|
Aug 16, 2023 |
|
Discussing Rheumatology: July 2023
|
Jul 19, 2023 |
|
PsA Podcast: Secukinumab in Oligoarticular PsA & JAK Inhibition-related Malignancies
|
Jul 12, 2023 |
|
Author Interview: Laura Coates
|
Jul 10, 2023 |
|
Author Interview: Mark Russell
|
Jul 07, 2023 |
|
Discussing Rheumatology: June 2023
|
Jun 26, 2023 |
|
AxSpA Podcast: Secukinumab Optimisation & Ixekizumab Treatment for PAEs
|
Jun 14, 2023 |
|
EULAR 2023 Highlights: Day 4
|
Jun 03, 2023 |
|
EULAR 2023 Highlights: Day 3
|
Jun 02, 2023 |
|
EULAR 2023 Highlights: Day 2
|
Jun 01, 2023 |
|
Discussing Rheumatology: May 2023
|
May 31, 2023 |
|
EULAR 2023 Highlights: Day 1
|
May 31, 2023 |
|
EULAR 2023 Preview Podcast
|
May 26, 2023 |
|
PsA Podcast: Guselkumab & Secukinumab – All the Latest in Efficacy & Safety
|
May 15, 2023 |
|
Author Interview: Shikha Singla
|
Apr 28, 2023 |
|
AxSpA Podcast: AS Associated MACE & Upadacitinib's Long Term Safety
|
Apr 19, 2023 |
|
Discussing Rheumatology: April 2023
|
Apr 12, 2023 |
|
PsA Podcast: Herpes Zoster In JAK Inhibitor Therapies & The APEX Protocol
|
Mar 31, 2023 |
|
Discussing Rheumatology: March 2023
|
Mar 30, 2023 |
|
Author Interview: Charis Meng
|
Mar 03, 2023 |
|
Discussing Rheumatology: February 2023
|
Feb 23, 2023 |
|
Discussing AxSpA: Episode 5
|
Feb 08, 2023 |
|
Discussing Rheumatology: January 2023
|
Feb 02, 2023 |
|
Author Interview: Kevin Winthrop
|
Feb 01, 2023 |
|
Discussing PsA: Episode 5
|
Jan 26, 2023 |
|
Author Interview: Rebecca Haberman
|
Jan 25, 2023 |
|
Author Interview: Roy Fleischmann
|
Jan 18, 2023 |
|
Author Interview: Claudia Salinas
|
Jan 13, 2023 |
|
Discussing Rheumatology: December 2022
|
Dec 23, 2022 |
|
Discussing AxSpA: Episode 4
|
Dec 14, 2022 |
|
Discussing Rheumatology: November 2022
|
Nov 24, 2022 |
|
Discussing PsA: Episode 4
|
Nov 09, 2022 |
|
Discussing Rheumatology: October 2022
|
Oct 28, 2022 |
|
Discussing AxSpA: Episode 3
|
Oct 12, 2022 |
|
Discussing Rheumatology: September 2022
|
Sep 28, 2022 |
|
Author Interview: Eduardo Mysler
|
Sep 28, 2022 |
|
Discussing PsA: Episode 3
|
Sep 13, 2022 |
|
Author Interview: Ameen Jubber
|
Aug 22, 2022 |
|
CSF Monthly Podcast August22
|
Aug 22, 2022 |
|
Author Interview: Kim Lauper
|
Aug 10, 2022 |
|
Discussing AxSpA: Episode 2
|
Aug 08, 2022 |
|
Discussing Rheumatology: July 2022
|
Jul 28, 2022 |
|
Discussing PsA: Episode 2
|
Jul 27, 2022 |
|
Author Interview: Diego Kyburz
|
Jul 25, 2022 |
|
Discussing Rheumatology: June 2022
|
Jul 18, 2022 |
|
Discussing axSpA: Episode 1
|
Jun 24, 2022 |
|
Discussing PsA: Episode 1
|
Jun 07, 2022 |
|
DAY 4: EULAR 2022 Daily Highlights
|
Jun 04, 2022 |
|
DAY 3: EULAR 2022 Daily Highlights
|
Jun 03, 2022 |
|
DAY 2: EULAR 2022 Daily Highlights
|
Jun 02, 2022 |
|
DAY 1, RA: EULAR 2022 Daily Highlights
|
Jun 01, 2022 |
|
DAY 1, PsA: EULAR 2022 Daily Highlights
|
Jun 01, 2022 |
|
DAY 1, axSpA: EULAR 2022 Daily Highlights
|
Jun 01, 2022 |
|
EULAR 2022 Preview Podcast
|
May 27, 2022 |
|
Discussing Rheumatology: May 2022
|
May 25, 2022 |
|
Author Interview: Professor Peter Taylor
|
Apr 28, 2022 |
|
Discussing Rheumatology: Pain, pneumonia and perspectives
|
Apr 28, 2022 |
|
Author Interview: Professor Rüdiger Müller
|
Apr 12, 2022 |
|
Discussing Rheumatology: March 2022
|
Apr 12, 2022 |
|
Author Interview: Professor Roy Fleischmann
|
Mar 16, 2022 |
|
Discussing Rheumatology: Tofacitinib safety and dose-switching in RA
|
Feb 24, 2022 |
|
ACR1540 Ana Rita Cruz - Machado
|
Feb 11, 2022 |
|
ACR1087 Omar Alsaed
|
Feb 11, 2022 |
|
ORAL Surveillance Author Interview – Roy Fleischmann
|
Feb 09, 2022 |
|
Author Author Interview: Professor Kevin Winthrop
|
Feb 03, 2022 |
|
Discussing Rheumatology: HZ and ILD with tofacitinib in RA
|
Jan 27, 2022 |
|
Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA
|
Dec 23, 2021 |
|
Author Interview: Professor Kevin Winthrop (December 2021)
|
Dec 23, 2021 |
|
Author Interview: Professor Kevin Winthrop (November 2021)
|
Dec 22, 2021 |
|
Insights at ACR 2021: Basic Science / Beyond RA
|
Dec 14, 2021 |
|
Insights at ACR 2021: PROs and JAK Treatment
|
Dec 13, 2021 |
|
Insights at ACR 2021: Clinical Outcomes in RA
|
Dec 12, 2021 |
|
Insights at ACR 2021: JAKs in Spondyloarthritis
|
Dec 11, 2021 |
|
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
|
Dec 10, 2021 |
|
Insights at ACR 2021: Impact of COVID-19 on Practice
|
Dec 09, 2021 |
|
Insights at ACR 2021: COVID Vaccinations
|
Dec 07, 2021 |
|
Author Interview: Professor Atul Deodhar
|
Dec 06, 2021 |
|
Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA
|
Dec 06, 2021 |
|
Author Interview: Professor Roy Fleischmann
|
Nov 18, 2021 |
|
ACR 2021: Day 4 Highlights
|
Nov 09, 2021 |
|
ACR 2021: Day 3 Highlights
|
Nov 08, 2021 |
|
ACR 2021: Day 2 Highlights
|
Nov 07, 2021 |
|
Discussing Rheumatology: Herpes Zoster and HBV
|
Nov 04, 2021 |
|
ACR 2021: Day 1 Highlights
|
Nov 04, 2021 |
|
ACR 2021 Preview Podcast
|
Nov 04, 2021 |
|
Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness
|
Oct 14, 2021 |
|
Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy
|
Sep 23, 2021 |
|
Rheumatology Author Professor Kurt de Vlam: Pain Improvements
|
Sep 10, 2021 |
|
Rheumatology Author Professor Strand: Upadacitinib and PROs
|
Sep 09, 2021 |
|
Discussing Rheumatology: Patient Reported Outcomes
|
Sep 09, 2021 |
|
Discussing Rheumatology: SELECT-PsA 2 and DMARDs in COVID-19
|
Jul 22, 2021 |
|
Rheumatology Author Professor Mease: Upadacitinib
|
Jul 21, 2021 |
|
Rheumatology Authors Jeffrey Sparks and Zachary Wallace
|
Jul 20, 2021 |
|
Rheumatology Author Professor Francesco Ciccia: JAKis and Pain
|
Jul 05, 2021 |
|
Discussing Rheumatology: 2021 EULAR Highlights
|
Jul 05, 2021 |
|
Rheumatology Author Professor Stanley Cohen: Radiographic Progression
|
Jun 23, 2021 |
|
Insights at EULAR 2021: Day 4 Highlights
|
Jun 05, 2021 |
|
Insights at EULAR 2021: Day 3 Highlights
|
Jun 04, 2021 |
|
Insights at EULAR 2021: Day 2 Highlights
|
Jun 03, 2021 |
|
Insights at EULAR 2021: Day 1 Highlights
|
Jun 02, 2021 |
|
Insights at EULAR 2021: Preview
|
Jun 01, 2021 |
|
Discussing Rheumatology: PsA and Radiographic Progression
|
May 28, 2021 |
|
Rheumatology Author Professor Yoshiya Tanaka: Filgotinib
|
May 13, 2021 |
|
Rheumatology Author Dr Rishi Desai: VTE
|
Apr 28, 2021 |
|
Discussing Rheumatology: JAKi and VTE
|
Apr 28, 2021 |
|
Rheumatology Author Dr Ben Nowell: ArthritisPower
|
Apr 01, 2021 |
|
Discussing Rheumatology: Bone and PRO
|
Mar 17, 2021 |
|
Rheumatology Author Professor Paul Emery: Baricitinib
|
Mar 09, 2021 |
|
Forum LIVE: Managing Patients During COVID
|
Mar 05, 2021 |
|
Rheumatology Author Professor Lee Simon: Pain in RA
|
Mar 03, 2021 |
|
Rheumatology Author Professor Tsutomu Takeuchi: Upadacitinib
|
Mar 03, 2021 |
|
Rheumatology Author Prof René Westhovens: Filgotinib
|
Feb 19, 2021 |
|
Discussing Rheumatology: February 2021 Podcast
|
Feb 19, 2021 |
|
Perspectives in Inflammation - Dr Grace Wright
|
Jan 29, 2021 |
|
Rheumatology Author Prof György Nagy: EULAR
|
Jan 27, 2021 |
|
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
|
Jan 18, 2021 |
|
Discussing Rheumatology: JAKi and TNFi
|
Jan 18, 2021 |
|
Perspectives In Inflammation - Professor Weinblatt
|
Jan 11, 2021 |
|
Rheumatology Author Prof Josef Smolen: Barcitinib
|
Jan 06, 2021 |
|
Rheumatology Author Dr Kerschbaumer: JAKinibs
|
Dec 29, 2020 |
|
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
|
Dec 29, 2020 |
|
Rheumatology Author Prof Kevin Winthrop: Tofacitinib
|
Dec 22, 2020 |
|
Discussing Rheumatology: JAK Inhibitors
|
Dec 22, 2020 |
|
Perspectives in Inflammation - Professor Emery
|
Dec 09, 2020 |
|
Insights at ACR 2020: Highlights from ACR 2020
|
Nov 30, 2020 |
|
Rheumatology Author Prof Stanley Cohen: Upadacitinib
|
Nov 25, 2020 |
|
Discussing Rheumatology: Upadacitinib Safety
|
Nov 25, 2020 |
|
Insights at ACR 2020: Efficacy And Safety Of JAK Inhibitors
|
Nov 23, 2020 |
|
Insights at ACR 2020: New Developments in Cytokine Signalling
|
Nov 23, 2020 |
|
Insights at ACR 2020: Bone And Patient Outcomes With RA
|
Nov 19, 2020 |
|
Insights at ACR 2020: Vaccinations and JAK Inhibitors
|
Nov 19, 2020 |
|
Rheumatology Author Gustavo Citera: Interstitial Lung Disease
|
Nov 18, 2020 |
|
Insights at ACR 2020: Day 4 RA Highlights
|
Nov 09, 2020 |
|
Insights at ACR 2020: Day 4 Beyond RA Highlights
|
Nov 09, 2020 |
|
Insights at ACR 2020: Day 3 RA Highlights
|
Nov 08, 2020 |
|
Insights at ACR 2020: Day 3 Beyond RA Highlights
|
Nov 08, 2020 |
|
Insights at ACR 2020: Day 2 RA Highlights
|
Nov 07, 2020 |
|
Insights at ACR 2020: Day 2 Beyond RA Highlights
|
Nov 07, 2020 |
|
Insights at ACR 2020: Day 1 RA Highlights
|
Nov 05, 2020 |
|
Insights at ACR 2020: Day 1 Beyond RA Highlights
|
Nov 05, 2020 |
|
Discussing Rheumatology: Baricitinib and Itacitinib
|
Nov 04, 2020 |
|
Insights at ACR 2020: Preview
|
Oct 30, 2020 |
|
Perspectives in Inflammation - Prof Bijlsma
|
Oct 15, 2020 |
|
Perspectives in Inflammation - Prof Azevedo
|
Oct 07, 2020 |
|
Rheumatology Author Kevin Winthrop: Infections in Baricitinib Clinical Trials
|
Oct 02, 2020 |
|
Rheumatology Author: Dr Eugen Feist and Dr Pedro López-Romero
|
Oct 02, 2020 |
|
Discussing Rheumatology: JAK Inhibitor Infection and Cardiovascular Risks
|
Sep 29, 2020 |
|
Perspectives in Inflammation - Prof Anja Strangfeld and Prof Loreto Carmona
|
Sep 18, 2020 |
|
Perspectives in Inflammation - Prof Leonard Calabrese
|
Sep 11, 2020 |
|
Rheumatology Author Vibeke Strand: Upadacitinib Monotherapy
|
Aug 27, 2020 |
|
Perspectives in Inflammation - Dr Enrique Soriano
|
Aug 26, 2020 |
|
Discussing Rheumatology: JAK Inhibitor Monotherapy in RA
|
Aug 21, 2020 |
|
Rheumatology Author Roy Fleischmann: Baricitinib Monotherapy
|
Aug 21, 2020 |
|
Rheumatology Author Kosuke Ebina: Drug Retention
|
Aug 06, 2020 |
|
Perspectives in Inflammation - Prof Chris Ritchlin
|
Aug 06, 2020 |
|
Rheumatology Author Georg Schett: SARS-CoV-2
|
Jul 31, 2020 |
|
Discussing Rheumatology: PsA and Drug Retention
|
Jul 22, 2020 |
|
Perspectives in Inflammation – Prof Maurizio Cutolo
|
Jul 07, 2020 |
|
Perspectives in Inflammation - Prof Chris Buckley
|
Jul 03, 2020 |
|
Rheumatology Author Axel Finckh: Drug Maintenance
|
Jun 26, 2020 |
|
Rheumatology Author Prof Gerd Burmester: PsA & Hep B
|
Jun 23, 2020 |
|
Rheumatology Author Dr Stanley Cohen: Fenebrutinib
|
Jun 23, 2020 |
|
Discussing Rheumatology: Baricitinib Safety and Treatment Interruptions
|
Jun 22, 2020 |
|
Insights at EULAR 2020: Safety Of JAK Inhibitors
|
Jun 17, 2020 |
|
Insights at EULAR 2020: Basic Science
|
Jun 17, 2020 |
|
Insights at EULAR 2020: Clinical Data on JAK Inhibitors
|
Jun 16, 2020 |
|
Insights at EULAR 2020: PRO & Real World
|
Jun 11, 2020 |
|
Insights at EULAR 2020: Beyond RA
|
Jun 11, 2020 |
|
Insights at EULAR 2020: Day 4 Highlights
|
Jun 06, 2020 |
|
Insights at EULAR 2020: Day 3 Highlights
|
Jun 05, 2020 |
|
Insights at EULAR 2020: Day 2 Highlights
|
Jun 04, 2020 |
|
Insights at EULAR 2020: Day 1 Highlights
|
Jun 03, 2020 |
|
Insights at EULAR 2020: Preview
|
Jun 02, 2020 |
|
Discussing Rheumatology: PsA & Hep B
|
May 27, 2020 |
|
COVID-19 Global Rheumatology Registry
|
May 11, 2020 |
|
Discussing Rheumatology: Vasculitis & Zoster
|
May 04, 2020 |
|
Rheumatology Author Prof Kevin Winthrop: Zoster
|
Apr 28, 2020 |
|
Rheumatology Registries for COVID-19
|
Apr 24, 2020 |
|
COVID-19: Considerations for Rheumatologists
|
Apr 22, 2020 |
|
Perspectives in Inflammation – Prof Pierre Miossec
|
Apr 09, 2020 |
|
Rheumatology Author Interview: Bone Homeostasis
|
Apr 02, 2020 |
|
Rheumatology Author Prof Georg Schett: Osteoblasts
|
Mar 27, 2020 |
|
Discussing Rheumatology: JAKi and Bone Biology
|
Mar 23, 2020 |
|
Perspectives in Inflammation - Prof Iain McInnes
|
Mar 11, 2020 |
|
Rheumatology Author Dr Orsolini: Osteoimmunology
|
Feb 26, 2020 |
|
Discussing Rheumatology: JAK Selectivity
|
Feb 21, 2020 |
|
Perspectives in Inflammation - Prof Anca Catrina
|
Feb 07, 2020 |
|
Rheumatology Author Prof Vibeke Strand: PROs
|
Jan 29, 2020 |
|
Discussing Rheumatology: Tofacitinib Improves PROs
|
Jan 22, 2020 |
|
Perspectives In Inflammation - Prof Kevin Winthrop
|
Jan 08, 2020 |
|
Highlights of 2019
|
Dec 23, 2019 |
|
December 2019 Monthly Podcast
|
Dec 23, 2019 |
|
November 2019 Monthly Podcast
|
Nov 28, 2019 |
|
Congress Author Podcast - ACR 2019 Filgotinib
|
Nov 22, 2019 |
|
Congress Author Podcast - ACR 2019 Tofacitinib and Baricitinib
|
Nov 22, 2019 |
|
Congress Author Podcast - ACR 2019 Upadacitinib
|
Nov 22, 2019 |
|
ACR 2019 - Day 4 Highlights
|
Nov 19, 2019 |
|
ACR 2019 - Day 3 Highlights
|
Nov 19, 2019 |
|
ACR 2019 - Day 2 Highlights
|
Nov 19, 2019 |
|
ACR 2019 - Day 1 Highlights
|
Nov 19, 2019 |
|
October 2019 Monthly Podcast
|
Oct 31, 2019 |
|
September 2019 Monthly Podcast
|
Sep 26, 2019 |
|
Author Interview - Professor Fleischmann
|
Sep 19, 2019 |
|
Author Interview - Professor Calabrese
|
Sep 09, 2019 |
|
Perspectives in Inflammation - Professors Iain McInnes and Johannes Bijlsma
|
Sep 09, 2019 |
|
August 2019 Monthly Podcast
|
Aug 27, 2019 |
|
Author Interview - Dr Roland Grenningloh
|
Aug 14, 2019 |
|
July 2019 Monthly Podcast
|
Jul 29, 2019 |
|
June 2019 Monthly Podcast
|
Jun 27, 2019 |
|
Author Interview - Professor Winthrop
|
May 30, 2019 |
|
May 2019 Monthly Podcast
|
May 23, 2019 |
|
Author Interview - Professor Combe
|
May 10, 2019 |
|
April 2019 Monthly Podcast
|
Apr 25, 2019 |
|
Author Interview - Professor Takeuchi
|
Apr 23, 2019 |
|
Speciality Podcast - Pain Podcast
|
Apr 10, 2019 |
|
March 2019 Monthly Podcast
|
Mar 22, 2019 |
|
Author Interview - Professor Taylor
|
Mar 13, 2019 |
|
February 2019 Monthly Podcast
|
Mar 04, 2019 |
|
January 2019 Monthly Podcast
|
Jan 28, 2019 |
|
December 2018 Monthly Podcast
|
Jan 11, 2019 |
|
Author Interview - Florence Namour
|
Jan 07, 2019 |
|
November 2018 Monthly Podcast
|
Dec 04, 2018 |
|
Author Interview - Professor Curtis
|
Dec 04, 2018 |
|
ACR Author Interviews
|
Nov 16, 2018 |
|
October 2018 Monthly Review
|
Oct 29, 2018 |
|
September 2018 Monthly Review
|
Oct 09, 2018 |
|
Author Interview - Professor Emery
|
Oct 03, 2018 |
|
August 2018 Monthly Review
|
Aug 28, 2018 |
|
Author Interview - Professor Atzeni
|
Aug 24, 2018 |
|
July 2018 Monthly Review
|
Jul 25, 2018 |
|
June 2018 Monthly Review
|
Jul 05, 2018 |
|
Author Interview - Professor Strand
|
May 30, 2018 |
|
May 2018 Monthly Review
|
May 23, 2018 |
|
April 2018 Monthly Review
|
Apr 27, 2018 |
|
March 2018 Monthly Review
|
Mar 29, 2018 |
|
Author Interview - Professor Fleischmann
|
Mar 29, 2018 |
|
Author Interview - Xavier Teitsma
|
Feb 28, 2018 |
|
February 2018 Monthly Review
|
Feb 28, 2018 |
|
Author Interview - Professor Choy
|
Feb 02, 2018 |
|
January 2018 Monthly Review
|
Jan 29, 2018 |
|
December 2017 Monthly Review
|
Dec 21, 2017 |
|
November 2017 Monthly Review
|
Nov 29, 2017 |
|
October 2017 Monthly Review
|
Oct 30, 2017 |
|
September 2017 Monthly Review
|
Sep 21, 2017 |
|
August 2017 Monthly Review
|
Aug 21, 2017 |
|
July 2017 Monthly Review
|
Jul 25, 2017 |
|
June 2017 Monthly Review
|
Jun 26, 2017 |
|
April 2017 Monthly Review
|
May 11, 2017 |
|
March 2017 Publications
|
May 11, 2017 |
|
October 2016 publications update
|
Nov 23, 2016 |
|
September 2016 publications
|
Nov 23, 2016 |
|
July 2016 publications
|
Jul 28, 2016 |
|
February 2016 publications
|
Mar 03, 2016 |
|
January 2016 publications
|
Mar 03, 2016 |
|
December publications update
|
Dec 22, 2015 |
|
October publications update
|
Oct 21, 2015 |
|
ACR 2015 Congress Highlights
|
Oct 21, 2015 |